Nilaya Varma, Co-Founder & Chief Executive Officer, Primus Partners, shares his view on rising volatility in the UK market and geopolitical pressures impacting exports, while highlighting diversification into emerging markets, resilience in vaccine exports, and the potential of the India–UK CETA to boost pharmaceutical trade and complex generics.